JOEL ACKERMAN - 30 Oct 2025 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Role
Director
Signature
/s/ Joel Ackerman
Issuer symbol
CSBR
Transactions as of
30 Oct 2025
Net transactions value
$0
Form type
4
Filing time
06 Nov 2025, 11:19:39 UTC
Previous filing
18 Mar 2025
Next filing
07 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ACKERMAN JOEL Director C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLACE, SUITE 307, HACKENSACK /s/ Joel Ackerman 30 Oct 2025 0001220630

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSBR Common Stock Options Exercise $198,250 +94,405 +9.8% $2.10 1,056,539 30 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSBR Option to purchase Common Stock Options Exercise $198,250 -94,405 -100% $2.10 0 30 Oct 2025 Common Stock 94,405 $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016.